Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
76.86 CHF | -1.00% |
|
-0.77% | -.--% |
Jul. 15 | Brace for a flurry of speeches from Fed officials | ![]() |
Jul. 15 | European companies cut jobs as economy sputters | RE |
Sales 2024 * | 49.29B 43.76B | Sales 2025 * | 51.41B 45.64B | Capitalization | 225B 200B |
---|---|---|---|---|---|
Net income 2024 * | 10.99B 9.76B | Net income 2025 * | 12.22B 10.85B | EV / Sales 2024 * | 4.84 x |
Net Debt 2024 * | 13.22B 11.74B | Net Debt 2025 * | 11.6B 10.3B | EV / Sales 2025 * | 4.61 x |
P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
18.5
x | Employees | - |
Yield 2024 * |
3.36% | Yield 2025 * |
3.48% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 week | -0.77% |
![Extreme 76.86](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.53% | 848B | |
+33.25% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.98% | 234B | |
+15.67% | 179B | |
+2.47% | 167B | |
+2.47% | 125B |
- Stock Market
- Equities
- NOVN Stock
- 0QM7 Stock